KDZ-22199-43261
2 vaccinations
6 coded responses
23 check-ins
5 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 752 / TX
- Registered
- 2022-07-09
- Relationship
- Child or adolescent in my care
- Guardian
- NU9-10803-49892
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-07-09
Registered in v-safe
-
2022-07-09
Dose 1 — Pfizer-BioNTech
-
2022-07-09
Survey response — day 0, dose 1, under 3MedDRA: Rhinorrhoea — Feeling: Fair · Site: PainFree text: Runny noseMedDRA releases: 2024-11 · check-in free text available
- 2022-07-10
-
2022-07-11
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Good · Fever · Irritability/cryingUnder 3 check-in
-
2022-07-12
Survey response — days 1–6 daily, dose 1, under 3MedDRA: Cough, Rhinorrhoea — Feeling: Fair · FeverFree text: Runny nose and coughMedDRA releases: 2024-11 · check-in free text available
- 2022-07-13
-
2022-07-14
Survey response — days 1–6 daily, dose 1, under 3MedDRA: Cough — Feeling: Fair · FeverFree text: CoughMedDRA releases: 2024-11 · check-in free text available
- 2022-07-15
- 2022-07-18
-
2022-07-23
Survey response — day 14, dose 1, under 3MedDRA: Pyrexia, Vomiting — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Vomiting, feverMedDRA releases: 2024-11 · check-in free text available
-
2022-07-23
Report sent to call center — day 14, dose 1, under 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-07-25
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-07-30
Dose 2 — Pfizer-BioNTech
-
2022-07-30
Health check-in — day 0, dose 2, under 3Feeling: Good · Site: Pain · Fever · SleepinessUnder 3 check-in
-
2022-07-31
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Fair · Fever · SleepinessUnder 3 check-in
- 2022-08-01
- 2022-08-02
- 2022-08-03
- 2022-08-04
- 2022-08-05
- 2022-08-06
- 2022-08-15
- 2022-08-27
- 2022-09-03
-
2022-09-10
Survey response — day 42, dose 2, under 3MedDRA: Rhinorrhoea — Feeling: GoodFree text: Runny noseMedDRA releases: 2024-11 · check-in free text available
- 2022-10-29
- 2023-01-28
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-07-09 | Pfizer-BioNTech | No |
| 2 | 2022-07-30 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-07-23 | Successful 2022-07-25 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 12 (Under 3) — day 0, dose 1, under 3
Systemic reaction (other): Runny nose
Release 12 (Under 3) — days 1–6 daily, dose 1, under 3
Systemic reaction (other): Runny nose and cough
Systemic reaction (other): Cough
Release 12 (Under 3) — day 14, dose 1, under 3
Symptoms: Vomiting, fever
Release 12 (Under 3) — day 42, dose 2, under 3
Symptoms: Runny nose
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Vomiting | · | · | ✓ |
| SRO | Cough | · | · | ✓ |
| SRO | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release